Lixte Biotechnology Holdings Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
/ 
Frequently asked questions
To buy Lixte Biotechnology Holdings Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Lixte Biotechnology Holdings Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Lixte Biotechnology Holdings Inc is LIXT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Lixte Biotechnology Holdings Inc has its primary listing on NASDAQ (Small cap). You can trade Lixte Biotechnology Holdings Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Lixte Biotechnology Holdings Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Lixte Biotechnology Holdings Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Lixte Biotechnology Holdings Inc.